ALD-601

N/A

Report date: 2023/01/12 16:07:10

Base Information

Drug NameALD-601
Drug Alias NameALD-601
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsLysosomal Storage DiseasesMetabolism, Inborn Errors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNuo Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAldagen Inc
Active IndicationsN/A
Inactive IndicationsLysosomal Storage DiseasesMetabolism, Inborn Errors

Other Information

ATC CodeN/A
Related LinksN/A